2018

Garabrant DH, Pastula ST. 2018. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans. Toxicol Appl Pharmacol 361(15 Dec):127–136; doi: 10.1016/j.taap.2018.07.003.

View Abstract

2017

Garabrant D, Pastula S. Asbestos and EMP fiber potency analysis. Abstract and oral presentation, Monticello Conference, Charlottesville, VA, October 2017.

2016

Garabrant DH, Alexander DD, Miller PE, Fryzek JP, Boffetta P, Teta MJ,… Kelsh MA, et al. 2016. Mesothelioma among motor vehicle mechanics: An updated review and meta-analysis. Ann Occup Hyg 60(1):8–26; doi: 10.1093/annhyg/mev060. PMID: 26318158.

View Abstract

2008

Wagner ME, Travis LB. 2008. Letter to the editor re: “Mesothelioma and asbestos.” Regul Toxicol Pharmacol 52(3):353–354 (author reply, 355); doi: 10.1016/j.yrtph.2008.07.001. PMID: 18680780.

2007

Kelsh MA, Craven VA, Teta MJ, Mowat FS, Goodman, M. 2007. Mesothelioma in vehicle mechanics: Is the risk different for Australians? Occup Med 57(8):581–589; doi: 10.1093/occmed/kqm114. PMID: 17965448.

    View Abstract

    2006

    Kelsh MA, Berman DW, Langer AW. 2006. Residential proximity to naturally occurring asbestos and mesothelioma risks: Further consideration of exposure misclassification and occupational confounding. Am J Respir Crit Care Med 174(12):1400; doi: 10.1164/ajrccm.174.12.1400. PMID: 17158287.

    View Abstract